(Q43637038)

25 November 2017

Statins: new American guidelines for prevention of cardiovascular disease (English)

1 reference

25 November 2017

cardiovascular disease

1 reference

1

Paul M Ridker

1 reference

25 November 2017

2

Nancy R Cook

1 reference

PubMed ID

24268611

25 November 2017

language of work or name

English

0 references

publication date

20 November 2013

1 reference

25 November 2017

1 reference

25 November 2017

382

1 reference

25 November 2017

9907

1 reference

25 November 2017

1762-1765

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

A trial-based approach to statin guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Rosuvastatin in older patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Use and misuse of the receiver operating characteristic curve in risk prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962388-0

7 January 2021

10.1016/S0140-6736(13)62388-0

Identifiers

DOI

1 reference

25 November 2017

1 reference

PubMed ID

24268611